Answers are grounded in this paper and cite their sources.
Women with recurrent urinary tract infections treated with cefuroxime axetil (500 or 250 mg twice daily) for 7 days had a higher relapse rate when tested 6 weeks after the start of treatment than those given amoxycillin (250 mg three times daily). The poor performance of cefuroxime axetil is explained by variable bioavailability.
No takes yet. Share an insight, caveat, or question.
Brumfitt et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: